FACULTY DISCLOSURE |
NAME |
RELATIONSHIP |
COMPANY |
Glynis Ablon, MD, FAAD |
Contracted Research |
Galderma, Nutrafol, Viviscal |
Brian Berman, MD, PhD |
|
Biofrontera, Advisory Board Honoraria Investigator, Celumigen, Consultant Stock Options, Dermira, Advisory Board & Consultant Stock Options, Dr. Tattoff, Advisory Board Stock Options, SUN Pharmaceuticals, Inc Advisory Board & Consultant Honoraria, Exeltis, Consultant & Investigator Honoraria, Ferndale Laboratories, Inc., Consultant Investigator Honoraria, FBM Therapeutics, Consultant Stock Options, Galderma Laboratories, L.P. Advisory Board Honoraria, GlaxoSmithKline, Consultant Honoraria, Klara/Goderma, Inc. Consultant Stock Options, Intraderm, Consultant Stock Options, LEO Pharma, US Speaker, Advisory Board & Investigator Honoraria
Medimetriks Pharmaceuticals Inc., Consultant Honoraria, Miragen, Consultant Honoraria Investigator, Encore, Consultant Investigator, Siranomics, Consultant
Pierre-Fabre, Consultant, Novan, Consultant Honoraria, Novartis Pharmaceuticals Corp., Advisory Board & Speaker Honoraria, Sonoma (Oculus Innovative Sciences, Inc.), Consultant Stock Options, Sensus, Speaker Consultant Honoraria Investigator, Smith & Nephew, Advisory Board Honoraria, TopMD, Advisory Board Stock, Ortho Dermatologics/Valeant, International Speaker & Advisory Board, Cutanea, Advisory Board Honoraria, Birch BioMed, Advisory Board Honoraria, Encore Dermatology, Consultant Honoraria & Investigator, Aclaris, Consultant Honoraria, Aiviva, Consultant, Anacor Pharmaceuticals, Inc., Advisory Board & Investigator, Clark Pharmaceutical, Investigator, Tigercat Pharma, Inc Investigator, Menlo Therapeutics, Consultant honoraria & Investigator, Pulse, Consultant Investigator, Almirall, Consultant |
Brad Glick, DO, MPH |
Advisory Board |
Abbvie, Lilly Pharmaceuticals, Top MD |
Contracted Research |
Abbvie and Celgene |
Speakers Bureau |
Abbvie, Celgene, Janssen pharmaceuticals, LEO pharmaceuticals, Lilly pharmaceuticals, Novartis, Ortho Dermatologics, Pfizer, Sun Pharma, Sanofi/Genzyme and Regeneron |
Stock |
TopMD |
Leon Kircik, MD |
Advisory Board |
Aclaris, Allergan, Inc., Almirall, Anacor Pharmaceuticals, Biogen-Idec, Colbar, Celgene, Cipher, Connetics Corporation, EOS, Exeltis, Ferndale, Laboratories, Inc., Foamix, Genentech, Inc., Intendis, Innocutis, Isdin, Johnson & Johnson, Nano Bio, OrthoNeutogena, Promius, Quinnova, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma,, Valeant Pharmaceuticals Intl, Warner-Chilcott |
Consultant |
Allergan, Inc., Almirall, Amgen, Inc., Anacor Pharmaceuticals, Colbar, Cipher, CollaGenex, Connetics Corporation, Exeltis, Foamix, Genentech, Inc., Intendis, Isdin, Johnson & Johnson, Laboratory Skin Care Inc, LEO, Medical International Technologies, Merck, Merz, Novartis AG, OrthoNeutrogena, Promius, PuraCap, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Taro, UCB, Valeant Pharmaceuticals, ZAGE |
Contracted Research |
Acambis, Allergan, Inc., Amgen, Inc., Anacor Pharmaceuticals, Astellas Pharma US, Inc., Asubio, Berlex Laboratories (Bayer HealthCare Pharmaceuticals),Biolive, Biopelle, Boehringer-Ingleheim, Breckinridge Pharma, Celgene, Centocor, Inc. Cellceutix, Coherus, CollaGenex, Combinatrix, Connetics Corporation, Coria, Dermavant, Dermira, Dow Pharmaceutical Sciences, Inc.,, DUSA, Eli Lilly, Exeltis, Ferndale Laboratories, Inc., Foamix, Genentech, Inc., GlaxoSmithKline, PLC, Healthpoint, LTD, Idera, Intendis, Innocutis, Johnson & Johnson, LEO, L’Oreal, 3MMaruho, Medicis Pharmaceutical Corp., Merck, Nano Bio, Novartis AG, Noven Pharmaceuticals, Nucryst Pharmaceuticals Corp, Obagi, Onset, OrthoNeutrogena, Promius, QLT, Inc.Quinnova, Quatrix, , PharmaDerm, Pfizer, SkinMedica, Inc., Stiefal Laboratories, Inc., Sun Pharma, TolerRX, UCB, Valeant Pharmaceuticals Intl, Warner-Chilcott, XenoPort |
Speakers Bureau |
Abbott Laboratories, Allergan, Inc., Amgen, Inc., Assos Pharma, Astellas Pharma US, Inc., Cipher, CollaGenex, Connectics Corporation, Dermik Laboratories, Embil Pharmaceuticals ,Exeltis, Foamix, Genentech, Inc., Innocutix, Innoval, Johnson & Johnson, LEO, L’Oreal, 3M, Onset, OrthoNeutrogena, PediaPharma, PharmaDerm, Serono (Merck Serono International SA),SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Taro, Triax, UCB, Valeant Pharmaceuticals, Intl, Warner-Chilcott, |
Stock |
Johnson & Johnson |
Mark Lebwohl, MD |
Consultant |
Allergan, Aqua, Arcutis, Inc., Boehringer Ingelheim, Bristol Myers Squibb, Leo Pharma Menlo, Mitsubishi, Neuroderm, Promius, Theravance, Verrica |
Contracted Research (paid to employer Mt Sinai) |
Abbvie, Amgen, Arcutis, Bausch Health (Valeant) Boehringer Ingelheim, Celgene, Eli Lilly, Incyet, Johnson & Johnson (Centocor, Janssen), Leo Pharmaceuticals, Medimmune/AstraZenecea, Novartis, Pfizer (Anacor), Regeneron, Sciderm, UCB, Inc., ViDac |
Giuseppe Micali, MD |
N/A |
Nothing to disclose |
David Pariser, MD |
Advisory Board |
Pfizer, Inc. |
Consultant |
Atacama Therapeutics, Bickel Biotechnology, Biofrontera AG, Celgene Corporation, Dermira, DUSA Pharmaceuticals, Inc., LEO Pharma, US, Novartis Pharmaceuticals Corp, Promius Pharmaceuticals, Regeneron, Sanofi, TDM SurgiTech, Inc, TheraVida, Valeant Pharmaceuticals International |
Contracted Research |
Abbott Laboratories, LEO Pharma, US |
Lawrence Schachner, MD |
Consultant |
Beiersdorf, Cutanea, Hoth, Lexington, Mustela, TopMD |
Contracted Research |
Astellas, Berg Pharma, Ferndale Labs, Lilly, Medimetrics, Novartis, Organogenesis Inc., Pfizer, Stiefel Laboratories |
PLANNER DISCLOSURES |
AKH & SBS Staff/Planners |
N/A |
Nothing to disclose |
|